The event BioInterface 2006 will take place on December 4-6, 2006 in San Mateo, CA. Highlights include the Excellence in Surface Science Award, Students Town Hall Meeting, a Student Poster Award competition, a lively debate session and an Invention Symposium! A workshop will focus on Delivery of Therapeutic Biologics. The technical program will also focus on Orthopedics to highlight important technologies and solid sessions in Tissue Imaging, Tissue Engineering and Peripheral Vascular technologies.

The event Celebrating the Entrepreneur will take place on December 4, 2006 at San Francisco City Hall in San Francisco, CA.  The event host committee will include the following: WTC Founder, Catherine Muther;  San Francisco Mayor Gavin Newsom; United States Senator, Barbara Boxer; United States Senator Dianne Feinstein; Congresswoman and House Democratic Leader Nancy Pelosi;  Assemblyman Mark Leno; Former San Francisco Supervisor Leslie Katz; Congressman Mike Honda; Franklin "Pitch" Johnson, Founding Partner Asset Management ; and Brook Byers, Partner at Kleiner Perkins Caufield & Byers.

The event Understanding the Challenges of the Changing Oncology Marketplace will take place on December 4, 2006 at the Mariott San Francisco Airport, 1800 Old Bayshore Highway, in Burlingame, CA. The following issues will be discussed:  how global data sets surrounding epidemiology, treatment data, chemotherapy utilization, and the need to be on top of key market changes in terms of new agents, regimens, cooperative group studies and general trends.

The event PG Open Meeting and Holiday Party will take place on November 30, 2006 from 4:30 p.m. – 6:30 p.m. at BIOCOM, 4510 Executive Drive, Plaza 7 in San Diego, CA.

The event Nanotechnology in Cancer Research will take place on November 30, 2006 from 4:30 – 7:30 p.m. at the Moores UCSD Cancer Center, Goldberg Auditorium in San Diego, CA. The conference will help determine how Centers for Nanotchnology Excellence (“CCNE”) will make a difference in the future. San Diego-based Nano Tumor Center leaders will share the progress on research projects and plans for commercialization.

The event VWR BD/Bioscience Lunch and Learn–Peptones:  High Quality Supplements for BioPharmaceutical Production  will take place on November 28, 2006 from 11:30 a.m. to 1:30 p.m. at BIOCOM, 4510 Executive Drive, Plaza 7 in San Diego, CA. Kathie Fritchman will discuss how peptone supplementation has increased over the years as more pharma companies have successfully incorporated peptones into their cell culture production processes.

The event BioE2E’s Fourth Annual Pitch Event will take place on November 17, 2006 from 9 a.m.- 1.30 p.m. at California Pacific Medical Center Research Institute, 475 Brannan Street, Suite 220, in San Francisco, CA. The Pitch Event is a master-class format where seasoned and raw entrepreneurs are welcome to learn about crafting and pitching their life sciences pitch. Students, academics, intra- and entrepreneurs are all welcome to submit. 
 

The event Peninsula Structures: Focus on the Future will take place on November 16, 2006 from 7:30 – 9:45 a.m. at the San Mateo Marriott Hotel, 1770 South Amphlett Boulevard, in San Mateo, CA. The discussion will involve issues including: expansion of tech startups and life science firms taking more office space, the rapid hiring for this expansion, and how employees are commuting from the East Bay, creating transit challenges.

The event LabWize Best Practices for Laboratory Design 2006 will take place from November 15-16, 2006 at the Clarion Hotel in San Francisco, CA. This event is targeted toward Owners, Architects, Engineers, Contractors and Manufacturers, who specialize in Health and Safety, Laboratory Buildings and Cleanrooms, or those who wish to learn about the State-Of-The-Art Design and Construction, Equipment and Materials these critical environments require.

The event New Directions in Analgesic Drug Development will take place on November 15, 2006 at 6 p.m. at The Clarion Hotel, 401 East Millbrae Ave., in Millbrae, CA. Speaker: William K Schmidt
President, Northstar Consulting. The discussion includes significant new approaches for reducing pain and controlling the side effects of existing drugs and selected products currently in advanced preclinical development or phase I-III clinical development for acute or chronic pain.